Docket
337-1030,
United States International Trade Commission
(Oct. 26, 2016)
Theodore R. Essex, presiding
Case Type | Sec 337 |
| Anhui Jinhe Industrial |
Complainant | Celanese International |
Complainant | Celanese IP Hungary BT |
Cite Docket
Certain High-Potency Sweeteners, Processes for Making Same, and Products Containing the Same, 337-1030 (U.S.I.T.C.)
+ More Snippets
Document
Vitaworks IP, LLC et al v. Glanbia Nutritionals (NA), Inc., et al.,, 1:19-cv-02259, No. 294 (D.Del. Jul. 27, 2023)
The Court entered an Order assigning me to serve as a special master to hear and decide discovery disputes in this litigation.
It is my understanding that Plaintiffs have agreed to produce documents related to Dr. Song’s interactions with AoKe and Jiaao and his communications with other third parties concerning licensing Plaintiffs’ taurine-related patents.
Following receipt of the photographs and any inspection of the hard copies, should Defendants still require additional information, they should meet and confer with Plaintiffs and if necessary, reach out to me with any further disputes on this issue.
Plaintiffs allowed Defendants to look in the room, but they were not permitted to inspect the interior of a cabinet that appeared to contain a large bottle of white powder and several closed compartments.
Alternatively, the parties could meet and confer to find a potential compromise result whereby Plaintiffs produce a detailed inventory along with photographs of the contents of the room.
Cite Document
Vitaworks IP, LLC et al v. Glanbia Nutritionals (NA), Inc., et al.,, 1:19-cv-02259, No. 294 (D.Del. Jul. 27, 2023)
+ More Snippets
Document
RENEX NY CORP. v. SUPPLY DEPOT LLC et al, 2:23-cv-00489, No. 42 (D.N.J. Jul. 18, 2023)
Nonetheless, as these admissions by Defendant and Zima are not sworn statements, and it is unclear if Plaintiff received Defendant's email5, see Def. Mot. for Sanctions Ex. A, Rule 11 dictates that any doubt be resolved in favor of the ...
Cite Document
RENEX NY CORP. v. SUPPLY DEPOT LLC et al, 2:23-cv-00489, No. 42 (D.N.J. Jul. 18, 2023)
+ More Snippets
Document
Vitaworks IP, LLC et al v. Glanbia Nutritionals (NA), Inc., et al.,, 1:19-cv-02259, No. 289 (D.Del. Jul. 13, 2023)
Motion to StayGranted
230 regarding the scope of Defendants' requested inspection of Vitaworks' facilities; and (iv) QYP' s Motion To Compel Compliance with, and Remedy Violation of, the Stipulated Protective Order (D.I.
As for the first factor, granting a stay pending the Court' s resolution of various disputes bearing on Vitaworks ' Court-ordered right to conduct a second inspection of QYP' s plant will simplify the issues for trial.
Indeed, QYP' s Emergency Motion seeks sanctions including "precluding Vitaworks' ability to shift the burden of infringement under 35 U.S.C. § 295."
Although fact discovery is set to close on July 14, 2023 , important factual issues remain outstanding, including Vitaworks' second inspection of QYP' s facility .
In addition to the Court's decision on Vitaworks' experts and QYP's Emergency Motion, other disputes impacting fact discovery remain pending, including two issues that have been referred to a Special Master (D.I.
Cite Document
Vitaworks IP, LLC et al v. Glanbia Nutritionals (NA), Inc., et al.,, 1:19-cv-02259, No. 289 (D.Del. Jul. 13, 2023)
+ More Snippets
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 160 (D.Del. Jun. 20, 2023)
Cite Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 160 (D.Del. Jun. 20, 2023)
+ More Snippets
Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 27 (D.N.J. Oct. 15, 2024)
Cite Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 27 (D.N.J. Oct. 15, 2024)
+ More Snippets
Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 28 (D.N.J. Oct. 15, 2024)
Cite Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 28 (D.N.J. Oct. 15, 2024)
+ More Snippets
Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 25 (D.N.J. Oct. 11, 2024)
Cite Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 25 (D.N.J. Oct. 11, 2024)
+ More Snippets
Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 16 (D.N.J. Sep. 24, 2024)
Cite Document
SPACEMAKER SYSTEMS, INC. v. FRAZIER INDUSTRIAL COMPANY, 3:24-cv-09279, No. 16 (D.N.J. Sep. 24, 2024)
+ More Snippets
Document
HexcelPack, LLC v. Pregis LLC, 1:23-cv-15282, No. 55 (N.D.Ill. Sep. 16, 2024)
Cite Document
HexcelPack, LLC v. Pregis LLC, 1:23-cv-15282, No. 55 (N.D.Ill. Sep. 16, 2024)
+ More Snippets
Document
SMARTE CARTE, INC. et al v. INNOVATIVE VENDING SOLUTIONS LLC, 1:19-cv-08681, No. 117 (D.N.J. Feb. 28, 2023)
Cite Document
SMARTE CARTE, INC. et al v. INNOVATIVE VENDING SOLUTIONS LLC, 1:19-cv-08681, No. 117 (D.N.J. Feb. 28, 2023)
+ More Snippets
Document
IPR2024-01219, No. 10 Notice Notice of deposition - Deposition Notice (P.T.A.B. Apr. 17, 2025)
Cite Document
IPR2024-01219, No. 10 Notice Notice of deposition - Deposition Notice (P.T.A.B. Apr. 17, 2025)
+ More Snippets
Document
Vitaworks IP, LLC et al v. Glanbia Nutritionals (NA), Inc., et al.,, 1:19-cv-02259, No. 174 (D.Del. Jan. 23, 2023)
Cite Document
Vitaworks IP, LLC et al v. Glanbia Nutritionals (NA), Inc., et al.,, 1:19-cv-02259, No. 174 (D.Del. Jan. 23, 2023)
+ More Snippets
Docket
337-,
United States International Trade Commission
Cite Docket
Certain Doxycline, 337- (U.S.I.T.C.)
+ More Snippets
Docket
17/755,721,
U.S. Patent Application
(Nov. 21, 2022)
Cite Docket
METHOD AND DEVICE FOR CLASSIFICATION OF URINE SEDIMENT GENOMIC DNA, AND USE OF URINE SEDIMENT GENOMIC DNA, 17/755,721 (U.S. Pat. App.)
+ More Snippets